Zobrazeno 1 - 10
of 247
pro vyhledávání: '"Jeffrey C Allen"'
Autor:
Joshua B. Rubin, David H. Gutmann, Joshua D. Schiffman, Jeffrey C. Allen, Uri Tabori, Michael J. Fisher, Karlyne M. Reilly, Jason T. Forys, Todd E. Druley, David Viskochil, David A. Stevenson, Douglas R. Stewart, Amanda Merkelson, Anne C. Albers, Debra Spoljaric, Sara Ganzhorn, Patricia C. Parkin, Robert C. McKinstry, Jingqin Luo, Tao Sun, Nicole M. Warrington
Supplemental Table 3. Primer sequences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4f70360ba51f1646bc2507f33ad8ee
https://doi.org/10.1158/0008-5472.22406085
https://doi.org/10.1158/0008-5472.22406085
Autor:
Joshua B. Rubin, David H. Gutmann, Joshua D. Schiffman, Jeffrey C. Allen, Uri Tabori, Michael J. Fisher, Karlyne M. Reilly, Jason T. Forys, Todd E. Druley, David Viskochil, David A. Stevenson, Douglas R. Stewart, Amanda Merkelson, Anne C. Albers, Debra Spoljaric, Sara Ganzhorn, Patricia C. Parkin, Robert C. McKinstry, Jingqin Luo, Tao Sun, Nicole M. Warrington
Supplemental Table 2: List of SNPs analyzed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1146c6d3e6309f8761bc9385a5813735
https://doi.org/10.1158/0008-5472.22406088
https://doi.org/10.1158/0008-5472.22406088
Autor:
Joshua B. Rubin, David H. Gutmann, Joshua D. Schiffman, Jeffrey C. Allen, Uri Tabori, Michael J. Fisher, Karlyne M. Reilly, Jason T. Forys, Todd E. Druley, David Viskochil, David A. Stevenson, Douglas R. Stewart, Amanda Merkelson, Anne C. Albers, Debra Spoljaric, Sara Ganzhorn, Patricia C. Parkin, Robert C. McKinstry, Jingqin Luo, Tao Sun, Nicole M. Warrington
Supplemental Table 1: Specimen Characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386b672bd56ed0549bd4e6631abc9e90
https://doi.org/10.1158/0008-5472.22406091
https://doi.org/10.1158/0008-5472.22406091
Autor:
Mekka R Garcia, Yang Feng, Varshini Vasudevaraja, Kristyn Galbraith, Jonathan Serrano, Cheddhi Thomas, Alireza Radmanesh, Eveline T Hidalgo, David H Harter, Jeffrey C Allen, Sharon L Gardner, Diana S Osorio, Christopher M William, David Zagzag, Daniel R Boué, Matija Snuderl
Publikováno v:
Journal of neuropathology and experimental neurology. 81(11)
Diffuse spinal cord gliomas (SCGs) are rare tumors associated with a high morbidity and mortality that affect both pediatric and adult populations. In this retrospective study, we sought to characterize the clinical, pathological, and molecular featu
Autor:
Peter E. Manley, Nathan Robison, Stewart Goldman, Michael Fisher, John P. Perentesis, Alan B. Cantor, Coretta Thomas, Bruce R. Korf, Alyssa Reddy, Mark W. Kieran, Susan N. Chi, Sanjay P. Prabhu, Nicole J. Ullrich, Tomoyuki Mizuno, Jeffrey C. Allen, Alexander A. Vinks, David Viskochil, Gary Cutter, Roger J. Packer, David H. Gutmann
Publikováno v:
Neuro-oncology, vol 22, iss 10
Neuro Oncol
Neuro Oncol
Background Activation of the mammalian target of rapamycin (mTOR) pathway is observed in neurofibromatosis type 1 (NF1) associated low-grade gliomas (LGGs), but agents that inhibit this pathway, including mTOR inhibitors, have not been studied in thi
Autor:
Thomas Czech, Mark M. Souweidane, D Haas-Kogen, Alexandre Vasiljevic, P Wen, C Faure Conter, Eric Bouffet, Jonathan L. Finlay, D. Frappaz, Matthew J. Murray, RD Kortmann, Ute Bartels, Dennis W. W. Shaw, Ching C. Lau, David Schiff, S Schöenberger, Jeffrey C. Allen, Girish Dhall, James Nicholson, P Robertson, Gabriele Calaminus, Claire Alapetite, Giovanni Morana, A Albanese, Stewart Goldman
The incidence of intracranial germ cell tumors (iGCT) is much lower in European and North American (E&NA) than in Asian population. However, E&NA cooperative groups have simultaneously developed with success treatment strategies with specific attenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c882403e8694b8154d9f9fa978e7ed
https://www.ncbi.nlm.nih.gov/pubmed/34724065
https://www.ncbi.nlm.nih.gov/pubmed/34724065
Autor:
Mohamed S. AbdelBaki, Christopher L. Tinkle, Girish Dhall, Rebecca Ronsley, Juliette Hukin, Roger J. Packer, Sabine Mueller, Jonathan L. Finlay, Joseph Stanek, Gregory K. Friedman, Kee Kiat Yeo, Tabitha Cooney, Ashley Margol, Lindsey Hoffman, Susan N. Chi, Amar Gajjar, Christina Coleman, Stephanie Villeneuve, Karen Gauvain, Jacob G. Ellen, Michael Fisher, Richard T Graham, Andrea Cappellano, Ute Bartels, Jack Su, Mohammad H Abu-Arja, Pournima Navalkele, John T. Lucas, Nicholas G. Gottardo, Jeffrey C. Allen
Publikováno v:
Pediatr Blood Cancer
BACKGROUND: Central nervous system (CNS) germinomas are treatment-sensitive tumors with excellent survival outcomes. Current treatment strategies combine chemotherapy with radiotherapy (RT) in order to reduce the field and dose of RT. Germinomas orig
Autor:
Qingwen Xu, Ekrem Maloku, Jaishri O. Blakeley, Audrey Mauguen, Thomas A. Neubert, Filippo G. Giancotti, Jingjing Deng, Nicholas A Vitanza, Scott R. Plotkin, Chandranath Sen, Erin M. Dunbar, Luis Chiriboga, Robert J. Schneider, Judith D. Goldberg, Matthias A. Karajannis, Shiyang Wang, J. Thomas Roland, John G. Golfinos, Dimitris G. Placantonakis, David Zagzag, Anna Yaffee, Jeffrey C. Allen
Publikováno v:
Mol Cancer Ther
Inhibition of mTORC1 signaling has been shown to diminish growth of meningiomas and schwannomas in preclinical studies, and clinical data suggest that everolimus, an orally administered mTORC1 inhibitor, may slow tumor progression in a subset of pati
Autor:
Chie Emoto, Nathan Robison, Brigitte C. Widemann, Brian Weiss, Stewart Goldman, Jeffrey C. Allen, James H. Tonsgard, Alexander A. Vinks, Nancy Ratner, Michael Fisher, Jaishri O. Blakeley, Bruce R. Korf, Pamela L. Wolters, Coretta Thomas Robinson, Lloyd J. Edwards, Eva Dombi, Elizabeth K. Schorry, Scott R. Plotkin, Tsuyoshi Fukuda, Gary Cutter, Roger J. Packer
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(7)
PURPOSE Patients with neurofibromatosis type 1 (NF1) frequently develop plexiform neurofibromas (PNs), which can cause significant morbidity. We performed a phase II trial of the MAPK/ERK kinase inhibitor, mirdametinib (PD-0325901), in patients with
Autor:
Nicole J. Ullrich, Stewart Goldman, Jeffrey C. Allen, Mark W. Kieran, Nathan Robison, Sanjay P. Prabhu, David H. Gutmann, Michael Fisher, Bruce R. Korf, David Viskochil, Roger J. Packer, John P. Perentesis
Publikováno v:
Pediatric Blood & Cancer. 68
Data for visual acuity (VA) after treatment of neurofibromatosis type 1-associated optic pathway gliomas (NF1-OPGs) are limited. We retrospectively collected VA, converted to logMAR, before and after targeted therapy with everolimus for NF1-OPG, and